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Reply
We sincerely thank these correspondents for their keen interest in
our work (1). Instantaneous wave-free ratio (iFR) would not have
been possible without fractional flow reserve (FFR). The authors
are strong supporters and regular users of pressure-derived indices
of stenosis severity in their clinical practice, and they acknowledge
the great impact that FFR has had on patient management. More
than an independent index of stenosis severity, iFR constitutes a
scientific attempt to get FFR-like measurements with further
simplification of the technique, with the aim of facilitating
adoption of physiology in the catheter laboratory and thus improv-
ing patient management. We are aware that FFR constitutes the
current paradigm of invasive stenosis assessment, and therefore, we
welcome the healthy criticisms and the hint of skepticism implicit
in the 3 letters sent to the Editor, occasionally with some déjà vu
of the initial reactions witnessed during the introduction of FFR.
Dr. Rudzinski and colleagues raise several excellent points. iFR
and FFR do agree best at higher values. But where they disagree,
historic teaching would be that FFR—in which resistance is
aggressively minimized—should always have the lower pressure
ratio. Actual observations are opposite to this. It is with relief thatwe find the mechanism for this has been extensively established in
the physiology literature. Intense pharmacological vasodilator
stimuli can disrupt natural regulatory mechanisms beyond their
homeostatic range, and lead to a paradoxical increase in microcir-
culatory resistance by reducing coronary perfusion pressure (2).
While previously obvious only in pressure flow studies, it can now
be seen in the elevation of the Pd/Pa ratio by adenosine in FFR,
because for the first time stable wave-free Pd/Pa can be measured
(iFR) without pharmacological interference by adenosine. These
paradoxical disturbances in resistance by adenosine are obvious in
the severe range, but cannot be assumed to be absent in the rest of
the wide spectrum. The Bland-Altman plot may have its upward
tilt to the left explained by this.
The scatter of the Bland-Altman plot has little scope to be
much narrower because, just as iFR comes with its intrinsic
variability, FFR also has intrinsic variability, most elegantly de-
scribed in the DEFER study, which showed that, within 10 min in
the same patient in the same expert hands, an FFR of 0.86 initially
could jump between 0.70 and 0.90 on repeated measure (3). For
this reason, neither iFR, nor FFR, nor any other measure, could
ever match FFR perfectly. Despite this, we are encouraged by the
fact that the scatter of our plot was much narrower than that in the
Bland-Altman plot, demonstrating the widely accepted excellent
relationship between FFR to positron emission tomography (4).
Contrary to the opinion of Dr. Finet and colleagues, we found
wave intensity analysis (WIA) a very useful tool to demonstrate in
a scientific and objective way how to overcome the limitations
imposed by using time-averaged pressures for FFR calculation. As
a matter of fact, WIA revealed the limits of the nice metaphor used
by Dr. Finet and colleagues depicting adenosine-FFR as a wind
tunnel, showing that, contrary to the constant laminar flow used in
a wind tunnel, constant variations (“bumps”) occur in the coronary
arteries as a result of waves generated from the aorta and the
microcirculation over the cardiac cycle, with the exception of a
short wave-free period within diastole that best fulfils the theoret-
ical requirements of FFR. Once this wave-free period was identi-
fied, we compared the values of coronary resistance with those
obtained with time-averaged pressures in FFR. The documented
similarity of resistance values shown in Figure 5 of our paper (1),
and not the absence of waves as such as suggested by Finet and
coworkers, stands as the cornerstone of iFR. Although seldom
found, FFR values around 0.2 can be found in clinical practice and
in some of the foundational papers of FFR (3,5).
The statement by Dr. Pijls and colleagues that “the validity of
iFR depends on the assumption that minimum resting myocardial
resistance during diastole is equivalent to the mean resistance
during maximum hyperemia” is incorrect. A more correct proposal
would be that the validity of iFR depends on the demonstration
that myocardial resistance during a specific part of diastole (iFR) is
similar in stability and magnitude to that calculated from whole
cycle averaged measurements during hyperemia (FFR). In our
paper, we highlighted that the reduction in myocardial resistance
in response to adenosine administration is largely due to a reduction
in its systolic component, a key issue to understand why the resis-
tances underlying FFR and iFR calculation are similar, but we did not
propose that diastolic myocardial resistance remains completely un-
changed during adenosine-induced hyperemia. However, if excessive
resistance explained the difference between iFR and FFR, the numer-
ical disagreement between them would be related to the difference in
resistance between the 2 states. But it is not (Fig. 1).
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derived index superior to FFR in the detection of ischemia-
generating stenoses, something that was already achieved by
diastolic FFR (6), but to tackle the problems that impede adoption
of pressure-derived physiology, in particular adenosine adminis-
tration, recently acknowledged by Pijls et al. (7) as the last
remaining barrier for routine use of FFR.
We are impressed by the study alluded to by Dr. Pijls and
colleagues, performed in such a large number of patients; again, we
are thankful for the interest shown by the correspondents in testing
our observations thoroughly. However, we cannot comment on its
results before seeing a peer-reviewed full publication reporting in
detail the methodology and algorithms used to measure iFR, which,
we believe, could be at variance with the methodology applied in our
paper, thus explaining the different results of the correlation.
Finally, we agree with the correspondents that further validation
of iFR is required before it can be recommended as an additional
tool in the clinical domain. To facilitate the achievement of this,
we wonder if the investigators would consider allowing the digital
data of the recently terminated FAME 2 trial to be analyzed, using
the validated iFR algorithm, by a mutually agreed, distinguished
neutral party? An understanding of iFR in such a cohort would be
invaluable in progressing toward our shared aim of increasing the
adoption of physiologically guided revascularization.
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